Adaptive Biotechnologies CSO Harlan S. Robins reports disposal of common shares worth $10.77 million

Reuters2026/07/23 23:35

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Adaptive Biotechnologies Chief Scientific Officer Harlan S. Robins exercised options for 284,800 common shares at USD 6.55 on July 21, 2026.
Robins sold 492,400 common shares the same day at weighted-average prices of USD 21.72 and USD 22.12.
Directly held common shares fell to 812,058 following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adaptive Biotechnologies Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001780851-26-000017), on July 23, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Adaptive Biotechnologies CSO Harlan S. Robins reports disposal of common shares worth $10.77 million

You may also like

Crypto prices